MeSH term
Frequency | Condition_Probility | Angiogenesis Inhibitors | 6 | 54.0 |
*Angiogenic Proteins | 6 | 75.0 |
Animals | 9 | 0.0 |
COS Cells | 3 | 0.0 |
Humans | 15 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Transfection | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mice | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Nerve Tissue Proteins/chemistry/*genetics/metabolism | 3 | 33.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Rats | 3 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Angiopoietin-2 | 2 | 3.0 |
Amino Acid Sequence | 6 | 0.0 |
DNA Primers | 2 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
Neovascularization, Pathologic/*genetics | 2 | 4.0 |
Nerve Tissue Proteins/chemistry/*genetics | 2 | 4.0 |
Protein Conformation | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Cell Adhesion Molecules, Neuronal/*metabolism | 2 | 9.0 |
Immunohistochemistry | 3 | 0.0 |
Endothelial Growth Factors/genetics | 2 | 2.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Lymphokines/genetics | 2 | 2.0 |
Vascular Endothelial Growth Factor A | 2 | 0.0 |
Vascular Endothelial Growth Factors | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Neovascularization, Physiologic/*physiology | 2 | 1.0 |
Neovascularization, Pathologic/genetics | 2 | 6.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Genes, p53/*physiology | 2 | 4.0 |
Cell Line | 2 | 0.0 |
